Every SEC Form 3/4/5 on record for this filer (CIK 1603347) — 1 issuer, 95 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc. | SVP, Chief Accounting Officer | 2015-12-18 → 2026-04-24 | 65 | −$3M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| RARE | 2026-03-02 | Sell | 1,632 | $22.80 | $37,210 | 48,670 |
| RARE | 2025-12-29 | Sell | 85 | $34.38 | $2,922 | 50,450 |
| RARE | 2025-09-18 | Sell | 64 | $29.17 | $1,867 | 50,242 |
| RARE | 2025-09-05 | Sell | 84 | $31.39 | $2,637 | 50,306 |
| RARE | 2025-03-03 | Sell | 967 | $42.10 | $40,711 | 50,265 |
1 of 1 issuers are covered and open a security page; the rest are on file here only.